Search results
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
Zacks via Yahoo Finance· 19 hours agoNovo Nordisk (NVO) reports better-than-expected first-quarter results, beating both earnings and...
Your Health: The connection between inflammation and poverty
WJET - WFXP Erie· 11 hours agoDiabetes, cardiovascular disease, arthritis, allergies and COPD — all are life-threatening...
Type 1 Diabetes Market Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading...
Digital Journal· 7 days agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 15 hours agoI would like to start this call by going through the performance highlights across our strategic aspirations before handing over the word to my...
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 16 hours agoThe surge reflects scorching demand for the medicine which, alongside sister diabetes drug Ozempic, has been hailed as revolutionary and helped to...
Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Tandem Diabetes Care's estimated fair value is US$50.92 based on 2 Stage Free Cash Flow...
Adding AI to artificial pancreas enhances efficiency, study finds
Medical Xpress· 14 hours agoIn the study, UVA researchers compared an advanced experimental artificial pancreas system—which...
Type 2 Diabetes Misconceptions Present 'Challenge' to Care
Medscape· 2 days agoA study in a primarily Hispanic population points to the need for improved communication between...
Promising new study with diabetes drug for people with Parkinson's disease
KTBS Shreveport· 3 days agoGLP-1 agonist drugs like Ozempic and Wegovy are extremely popular, and are effective treatments for ...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 2 days agoDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before...